SEC Form D · Amendment · filed March 23, 2018
Evelo Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Duncan P. Mchale · Cambridge, MAExecJennifer P. Glennon · Cambridge, MAExecWilliam P. Devaul · Cambridge, MAExecNoubar B. Afeyan, Ph.D · Cambridge, MADirectorTheodose A. Melas-Kyriazi · Cambridge, MADirectorBalkrishan (Simba) A. Gill, Ph.D · Cambridge, MAExec · DirectorLord Ara P. Darzi · Cambridge, MADirectorDavid R. Epstein · Cambridge, MADirectorMark P. Bodmer, Ph.D · Cambridge, MAExecDavid P. Perry · Cambridge, MADirectorRonan Guilfoyle · New Albany, OHDirectorJeffrey W. Harder · Houston, TXDirectorMarc W. Duncan · Houston, TXExecGeoff Ruddick · New Albany, OHDirectorDavid B. Kool · Los Angeles, CAExecDerrick W. Hale · Houston, TXExecBrian Waterhouse · New Albany, OHExecTed P. Wang · Redmond, WADirectorAalok W. Shah · Houston, TXExec · DirectorTony S. Kim · Los Angeles, CADirectorMayTech Partners LLC · New York, NYDirectorHassan Mahmoud · Secaucus, NJExec · DirectorAbed Elsamna · Secaucus, NJExecMayTech Capital Management LLC · New York, NYExecBenjamin Bixby · Watertown, MADirectorChris W. Jarrous · OAKLAND, CAExecCarter W. Dunlap · OAKLAND, CADirectorF. Jonathan N. Dracos · NEW YORK, NYDirectorJ. Michael N. O'Brien · NEW YORK, NYExecBrian T. Kelley · NEW YORK, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗